Annual report pursuant to Section 13 and 15(d)

Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities

v3.24.1
Income Taxes (Details) - Schedule of Deferred Tax Assets and Liabilities - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Deferred tax assets:    
Net operating loss carryforwards $ 16,460,534 $ 13,399,384
Amortization 318,546 165,476
Accrued compensation not currently deductible 75,638 343,787
Stock compensation 2,126,581 1,588,866
Accrued interest 150,502 150,502
Reserve for uncollectible notes receivable 162,770
Organizational costs deferred for tax purposes 8,125 8,125
Total deferred tax assets 19,302,696 15,656,140
Difference between book and tax basis related to:    
Technology license (351,791) (368,587)
Acquired in-process research and development (2,332,618)
Other (639,726) (555,880)
Total deferred tax liabilities (991,517) (3,257,085)
Total of deferred tax assets and liabilities 18,311,179 12,399,055
Valuation allowance (18,662,970) (15,016,414)
Total of deferred tax assets and liabilities, net $ (351,791) $ (2,617,359)